Update on EGFR-mutated non-small cell lung cancer

Update on EGFR-mutated non-small cell lung cancer

Show other versions (2)
Saved in:
Bibliographic Details
Other Authors: Baik, Christina (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2019.
Series:Henry Stewart talks. Biomedical & life sciences collection.
Subjects:
Antineoplastic agents.
Drug targeting.
Lungs > Cancer > Chemotherapy.
Lungs > Cancer > Genetic aspects.
Personalized medicine.
Antineoplastic Agents > therapeutic use.
Carcinoma, Non-Small-Cell Lung > drug therapy.
Carcinoma, Non-Small-Cell Lung > genetics.
Clinical Trials as Topic.
ErbB Receptors > physiology.
Exons.
Lung Neoplasms > drug therapy.
Lung Neoplasms > genetics.
osimertinib.
Piperazines.
Precision Medicine.
Online Access:https://hstalks.com/bs/4038/
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000ngm a2200000 a 4500
001 HST5064
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 191004s2019 enk|||||||||||s|||v|eng d
028 5 0 |a 5064  |b Henry Stewart Talks 
035 |a (UkLoHST)4038 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Baik, Christina,  |u (University of Washington School of Medicine, USA)  |4 spk 
245 1 0 |a Update on EGFR-mutated non-small cell lung cancer  |h [electronic resource] /  |c Christina Baik. 
260 |a London :  |b Henry Stewart Talks,  |c 2019. 
300 |a 1 online resource (1 streaming video file (29 min.) :  |b color, sound). 
490 1 |a The biomedical & life sciences collection,  |x 2056-452X 
500 |a Animated audio-visual presentation with synchronized narration. 
500 |a Title from title frames. 
505 0 |a Contents: Lung cancer occurrence and distribution -- Effectiveness of targeted therapies -- Exon 20 mutations -- Common mechanisms of resistance -- Osimertinib as a treatment for T790M -- MET and C797S mutations -- Current treatment approaches -- Ongoing questions faced by the NSCLC community. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Antineoplastic agents. 
650 0 |a Drug targeting. 
650 0 |a Lungs  |x Cancer  |x Chemotherapy. 
650 0 |a Lungs  |x Cancer  |x Genetic aspects. 
650 0 |a Personalized medicine. 
650 2 |a Antineoplastic Agents  |x therapeutic use. 
650 2 |a Carcinoma, Non-Small-Cell Lung  |x drug therapy. 
650 2 |a Carcinoma, Non-Small-Cell Lung  |x genetics. 
650 2 |a Clinical Trials as Topic. 
650 2 |a ErbB Receptors  |x physiology. 
650 2 |a Exons. 
650 2 |a Lung Neoplasms  |x drug therapy. 
650 2 |a Lung Neoplasms  |x genetics. 
650 2 |a osimertinib. 
650 2 |a Piperazines. 
650 2 |a Precision Medicine. 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection. 
856 4 0 |u https://hstalks.com/bs/4038/ 
999 |c 200353  |d 200353 

Similar Items